Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2001 2
2003 1
2007 1
2008 3
2009 1
2012 1
2013 1
2014 3
2015 6
2016 8
2017 7
2018 5
2019 4
2020 2
2021 3
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Metronomics chemotherapy: time for computational decision support.
Barbolosi D, Ciccolini J, Meille C, Elharrar X, Faivre C, Lacarelle B, André N, Barlesi F. Barbolosi D, et al. Cancer Chemother Pharmacol. 2014 Sep;74(3):647-52. doi: 10.1007/s00280-014-2546-1. Epub 2014 Aug 1. Cancer Chemother Pharmacol. 2014. PMID: 25082520 Review.
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.
Le TK, Cherif C, Omabe K, Paris C, Lannes F, Audebert S, Baudelet E, Hamimed M, Barbolosi D, Finetti P, Bastide C, Fazli L, Gleave M, Bertucci F, Taïeb D, Rocchi P. Le TK, et al. Among authors: barbolosi d. Mol Ther. 2023 Feb 1;31(2):471-486. doi: 10.1016/j.ymthe.2022.08.005. Epub 2022 Aug 13. Mol Ther. 2023. PMID: 35965411 Free PMC article.
Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer.
Barlesi F, Deyme L, Imbs DC, Cousin E, Barbolosi M, Bonnet S, Tomasini P, Greillier L, Galloux M, Testot-Ferry A, Pelletier A, André N, Ciccolini J, Barbolosi D. Barlesi F, et al. Among authors: barbolosi d. Cancer Chemother Pharmacol. 2022 Aug;90(2):149-160. doi: 10.1007/s00280-022-04455-x. Epub 2022 Jul 22. Cancer Chemother Pharmacol. 2022. PMID: 35867144 Clinical Trial.
45 results